Related Experiment Videos
ECM homeostasis in renal diseases: a genomic approach
M Eikmans1, J J Baelde, E de Heer
1Department of Pathology, Leiden University Medical Center, Building 1, LI-Q, PO Box 9600, 2300 RC Leiden, The Netherlands. M.Eikmans@LUMC.NL
Abstract:
Chronic renal disease is in general histologically accompanied by a vast amount of scar tissue, ie glomerulosclerosis and interstitial fibrosis. Scarring results from excessive accumulation of extracellular matrix (ECM) components, a process driven by a plethora of cytokines and growth factors. Studies in experimental renal disease which target these regulators using gene therapy limit or prevent the development of scarring. This review focuses specifically on the role of transforming growth factor-beta, platelet-derived growth factor, connective tissue growth factor, hepatocyte growth factor, and epidermal growth factor. The results obtained in animal models hold promise for molecular intervention strategies in human renal disease. Microarray technology allows large-scale gene expression profiling in kidney tissue to identify common molecular pathways in a step towards discovery of new drug targets. Molecular techniques are expected to be used for diagnostic and prognostic purposes in nephrological practice to supplement renal biopsy. Several studies already show that molecular techniques might be of use in routine diagnostic practice. Improvement of diagnosis and prediction of outcome in renal patients might lead to more efficient and earlier therapeutic intervention.
Insights
Targeting growth factors in kidney disease can reduce scarring. Molecular techniques show promise for improving diagnosis and treatment of chronic renal disease.
Area of Science:
- Nephrology
- Molecular Biology
- Pathology
Background:
- Chronic renal disease is characterized by significant scarring, including glomerulosclerosis and interstitial fibrosis.
- This scarring arises from excessive extracellular matrix accumulation, regulated by cytokines and growth factors.
Purpose of the Study:
- To review the role of specific growth factors (TGF-β, PDGF, CTGF, HGF, EGF) in renal scarring.
- To explore the potential of molecular interventions and diagnostic techniques in managing kidney disease.
Main Methods:
- Review of experimental studies in animal models of renal disease.
- Discussion of microarray technology for gene expression profiling.
- Analysis of molecular techniques for diagnostic and prognostic applications.
Main Results:
- Gene therapy targeting growth factor regulators can limit or prevent scarring in experimental models.
- Microarray analysis aids in identifying molecular pathways and potential drug targets.
- Molecular techniques demonstrate utility in routine diagnostic practice for nephrological conditions.
Conclusions:
- Molecular interventions targeting growth factors show promise for treating human renal disease.
- Advanced molecular techniques can enhance diagnosis, prognosis, and therapeutic strategies in nephrology.
- Improved diagnostics and outcome prediction can lead to earlier and more effective patient treatment.